Search results for "Normal"

showing 10 items of 2571 documents

Results of a Prospective, Open-Label Trial to Assess the Efficacy, Safety and Immunogenicity of Wilate® in Children Under 6 Years of Age with Inherit…

2011

Abstract Abstract 3330 Introduction: Wilate® is a new-generation plasma-derived concentrate of von Willebrand factor (VWF) and factor VIII (FVIII) developed for treatment of patients with von Willebrand disease (VWD) and haemophilia A. The objective of this study was to assess efficacy, safety and immunogenicity of Wilate in children below 6 years of age with inherited VWD. Methods: The prospective, multi-centre trial included patients with inherited VWD of any type below 6 years of age with insufficient response to DDAVP. Any clinical event requiring VWF/FVIII concentrate treatment within 1 year was treated with Wilate. Efficacy was recorded by using a 4-point VRS and in vivo recovery of F…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsbiologybusiness.operationbusiness.industryImmunogenicityImmunologyCell BiologyHematologyHaemophiliamedicine.diseaseOctapharmaBiochemistryVon Willebrand factorTolerabilityhemic and lymphatic diseasesInternal medicinemedicinebiology.proteinVon Willebrand diseaseDosingbusinessAdverse effectBlood
researchProduct

Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain

2002

Kalla O, Aaltonen J, Wahlstrom J, Lehtinen V, Garcia Cabeza I, Gonzalez de Chavez M. Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand 2002: 106: 265–275. © Blackwell Munksgaard 2002. Objective: To examine the association of duration of untreated psychosis (DUP) with early course characteristics in first-episode psychosis in Finland and Spain. Method: Eighty-six patients from Finland (49) and Spain (37) were evaluated on various early course characteristics. Results: The mean value of DUP was 4.0 months (median 2 months) for the Finnish patients and 9.9 months (median 2 months) for the Spanish ones. In both groups, long …

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPsychosisSocial environmentmedicine.diseaseCross-cultural studiesUntreated psychosisDevelopmental psychologyPsychiatry and Mental healthSocial supportSeverity of illnessdupmedicinePsychiatryPsychologyPsychosocialActa Psychiatrica Scandinavica
researchProduct

Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy - a rev…

2010

The management of mucopolysaccharidosis (MPS) is focused on the multi-organ, sometimes life-threatening, clinical manifestations that occur over time. In the past, the limited, symptom-based treatment options led physicians to adopt a palliative approach towards individual disease-associated complications. The availability of systemic treatments such as haematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT) has created a better prognosis for MPS patients, particularly when initiated early in life. As part of an integrated management approach, these therapies could be valuable in managing the ocular features that are present in many children with MPS. HSCT has b…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryMucopolysaccharidosismedicine.medical_treatmentEye diseasenutritional and metabolic diseasesEnzyme replacement therapyHematopoietic stem cell transplantationmedicine.diseaseeye diseasesSurgeryTransplantationOphthalmologymedicineOptic nervesense organsStem cellmedicine.symptomIntensive care medicinebusinessClinical & Experimental Ophthalmology
researchProduct

Von Willebrand-Syndrom - Blutungsrisiko bei HNO-Eingriffen im Kindesalter

1994

Von Willebrand's disease (vWD) is the most common inherited bleeding disorder. Typical clinical features such as bleeding after surgery or trauma might suggest the disease. We present a series of 24 patients with vWD treated between 1989 and 1992. Diagnosis was confirmed by a reduction in plasma factor VIII antigen concentration, reduction of ristocetin cofactor activity and reduced factor VIII activity. Seventeen of the patients underwent surgery (7 adenoidectomies, 8 tonsillectomies, 2 paranasal sinus operations) and received preoperative stimulation of von Willebrand factor (vWF) using DDAVP. This resulted in a rapid increase in plasma vWF concentration from an average of 56% before stim…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtybiologymedicine.diagnostic_testbusiness.industryPlasma factorStimulationGastroenterologySurgeryOtorhinolaryngologyVon Willebrand factorVon willebrandhemic and lymphatic diseasesInternal medicinebiology.proteinMedicineRisk factorbusinessReduced factor VIII activityComplicationcirculatory and respiratory physiologyPartial thromboplastin timeLaryngo-Rhino-Otologie
researchProduct

Reproductive Dysfunction in Classical and Nonclassical Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

2021

Patients with congenital adrenal hyperplasia (CAH) both with severe (classical CAH) and mild (nonclassical NCAH) forms exhibit a wide spectrum of reproductive dysfunction. In this review, only CAH cases with 21-hydroxylase deficiency (21-OHd) will be discussed, as they represent almost all of the patients in reproductive clinical settings.

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyendocrine system diseasesbiologybusiness.industry21-Hydroxylasenutritional and metabolic diseasesClinical settingsurologic and male genital diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsCongenital adrenal hyperplasia due to 21-hydroxylase deficiencyEndocrinologyInternal medicinemedicinebiology.proteinCongenital adrenal hyperplasiabusiness
researchProduct

Aneurysma des Ductus arteriosus Botalli

2000

A congenital aneurysm of the ductus arteriosus Botalli was detected by chest X-ray as an intrathoracic mass in a 7-day-old infant. Following confirmation of the diagnosis by echocardiography and MRI the aneurysm was successfully resected via left lateral thoracotomy without cardiopulmonary bypass. The postoperative course was uneventful. Six years after operation the patient is asymptomatic and growing normally. An intrathoracic mass may be considered in the differential diagnosis especially in infants and children. Aneurysms of ductus arteriosus potentially are associated with serious complications. Timely diagnosis and early surgical intervention are decisive for prevention of serious com…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCongenital aneurysmMagnetic resonance imagingmedicine.diseaseAsymptomaticlaw.inventionSurgeryAneurysmmedicine.anatomical_structurelawDuctus arteriosusInternal medicinecardiovascular systemmedicineCardiopulmonary bypassCardiologycardiovascular diseasesDifferential diagnosismedicine.symptomCardiology and Cardiovascular MedicinebusinessComplicationHerz
researchProduct

Oromandibular dystonia: A dental approach

2010

Oromandibular dystonia consists of prolonged spasms of contraction of the muscles of the mouth and jaw. Primary idiopathic forms and secondary forms exist. Secondary dystonia develops due to environmental factors; some cases of cranial dystonia after dental procedure have been reported, but the causal relationship between these procedures and dystonia remains unclear. Traumatic situations in the mouth, such as poor aligned dentures or multiple teeth extractions may cause an impairment of proprioception of the oral cavity, leading to subsequent development of dystonia. The clinical characteristics of oromandibular dystonia are classified according to the affected muscles. The muscles involve…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_treatmentDentistrystomatognathic systemTongueotorhinolaryngologic diseasesmedicineHumansGeneral DentistryDystoniaOrthodonticsProprioceptionbusiness.industryMeige SyndromeFocal dystonia:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOromandibular dystoniaMuscles of masticationBotulinum toxinnervous system diseasesstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyDentistryUNESCO::CIENCIAS MÉDICASSurgeryDenturesbusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Un modelo en Drosophila del mecanismo de patogénesis de las expansiones ctg en la distrofia miotónica.

2007

La distrofia miotónica tipo 1 (DM1) es una enfermedad neuromuscular que se debe auna expansión de repeticiones CTG inestables en la región 3' no traducida del genproteína kinasa de la DM (DMPK). La DM1 se caracteriza por la miotonía y distrofiamuscular que muestran los pacientes, los cuales también presentan cataratas,arritmias cardiacas y alteraciones neuropatológicas. A nivel bioquímico muestrandefectos en el procesado alternativo de pre-mRNAs específicos lo cual explica algunossíntomas definitorios de la DM1. El mecanismo de patogénesis se debe a la toxicidadde los RNAs con expansiones CUG para la célula. Varias proteínas de unión a RNA,como las proteínas humanas Muscleblind-like MBNL1-3…

congenital hereditary and neonatal diseases and abnormalitiesnoneFacultat de Biològiques575
researchProduct

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019

The quantification of enzyme activity in the patient treated with enzyme replacement therapy (ERT) has been suggested as a tool for dosage individualization, so we conducted a study to evaluate the relationship between glucocerebrosidase activity and clinical response in patients with Gaucher disease type I (GD1) to ERT. The study included patients diagnosed with GD1, who were being treated with ERT, and healthy individuals. Markers based on glucocerebrosidase activity measurement in patients' leucocytes were studied: enzyme activity at 15 min. post-infusion (Act(75)) reflects the amount of enzyme that is distributed in the body post-ERT infusion, and accumulated glucocerebrosidase activity…

congenital hereditary and neonatal diseases and abnormalitiesnutritional and metabolic diseases
researchProduct

The Australian Sheep-Goat Scale: An Evaluation of Factor Structure and Convergent Validity.

2018

The Australian Sheep-Goat Scale (ASGS) is a commonly used measure of belief in the paranormal. The scale contains items that index extrasensory perception (ESP), psychokinesis (PK), and life after death (LAD). Although, research employs the ASGS as both a general (unidimensional) and factorial (multidimensional) measure, few studies have examined the appropriateness of these solutions. Accordingly, the present paper tested the psychometric integrity of the ASGS via two studies. Study 1 assessed ASGS factorial structure using confirmatory factor analysis. To achieve this, merging of ASGS data from previously published studies and ongoing work created a heterogeneous sample of 1,601 responses…

convergent validityScale (ratio)lcsh:BF1-990Factor structurePsychokinesis050105 experimental psychology03 medical and health sciences0302 clinical medicineStatisticsExtrasensory perceptionPsychology0501 psychology and cognitive sciencesGeneral PsychologyReliability (statistics)Factor analysisOriginal Research05 social sciencesAustralian Sheep-Goat ScaleConfirmatory factor analysisbelief in the paranormalbifactor modellcsh:PsychologyConvergent validityRevised Paranormal Belief ScalePsychology030217 neurology & neurosurgeryFrontiers in psychology
researchProduct